Antihistamines & Postacute Sequelae of SARS-CoV-2: A Case Study

  • COVID
  • Thread starter Tom.G
  • Start date
  • Tags
    Study
In summary, the conversation discusses the potential use of antihistamines to treat postacute sequelae of SARS-CoV-2 infection (PASC). The journal article presents two cases where antihistamines were administered and resulted in significant improvement in symptoms and daily activities. Future studies are needed to further explore this potential treatment.
  • #1
Tom.G
Science Advisor
Gold Member
5,235
4,055
I know, it's a weasel-worded thread title.
The Journal article is titled:

Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection​

We describe 2 cases of PASC in response to opportune administration of over-the-counter antihistamines, with significant improvement in symptoms and ability to perform activities of daily living. Future studies are warranted...

Popular article:
https://www.sciencealert.com/there-s-evidence-antihistamines-may-help-treat-long-covid-symptoms

Journal article:
https://doi.org/10.1016/j.nurpra.2021.12.016

Cheers,
Tom
 
  • Like
Likes jim mcnamara
Biology news on Phys.org
  • #2
Hi Tom,

Thanks for sharing this article about the potential use of antihistamines to treat postacute sequelae of SARS-CoV-2 infection (PASC). The evidence presented in the journal article looks promising. I'm interested in seeing what further studies are conducted on this topic. Have you seen any other research on this topic?

Thanks again!
 

1. What are antihistamines and how do they work?

Antihistamines are a type of medication commonly used to treat allergies. They work by blocking the effects of histamine, a chemical released by the body in response to an allergen. This helps to relieve symptoms such as sneezing, itching, and runny nose.

2. Can antihistamines be used to treat postacute sequelae of SARS-CoV-2?

There is currently no evidence to suggest that antihistamines can effectively treat postacute sequelae of SARS-CoV-2, also known as long COVID. However, they may be used to manage specific symptoms such as allergies or respiratory symptoms that may occur in some long COVID patients.

3. What is the case study mentioned in the title?

The case study mentioned in the title refers to a specific research study that investigated the use of antihistamines in treating postacute sequelae of SARS-CoV-2. It involved a single patient and the results may not be applicable to all individuals with long COVID.

4. Are there any potential side effects of using antihistamines?

Like any medication, antihistamines can cause side effects in some individuals. Common side effects may include drowsiness, dry mouth, and dizziness. It is important to carefully read and follow the instructions on the medication label and consult with a healthcare professional if you experience any concerning side effects.

5. Is there a specific type of antihistamine that is recommended for use in long COVID patients?

Currently, there is no specific type of antihistamine that is recommended for use in long COVID patients. The choice of antihistamine may depend on individual symptoms and medical history. It is important to consult with a healthcare professional for personalized recommendations.

Similar threads

  • Biology and Medical
Replies
1
Views
981
  • Biology and Medical
Replies
1
Views
722
Replies
7
Views
1K
Replies
1
Views
715
  • Biology and Medical
Replies
1
Views
845
  • Biology and Medical
Replies
2
Views
860
Replies
9
Views
925
Replies
3
Views
1K
  • Biology and Medical
Replies
2
Views
696
Replies
1
Views
841
Back
Top